↓ Skip to main content

In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction

Overview of attention for article published in Orphanet Journal of Rare Diseases, November 2010
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
107 Dimensions

Readers on

mendeley
107 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction
Published in
Orphanet Journal of Rare Diseases, November 2010
DOI 10.1186/1750-1172-5-31
Pubmed ID
Authors

Mario Manto, Josep Dalmau, Adrien Didelot, Véronique Rogemond, Jérôme Honnorat

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 2%
United States 2 2%
United Kingdom 2 2%
France 1 <1%
Italy 1 <1%
South Africa 1 <1%
Spain 1 <1%
Poland 1 <1%
Unknown 96 90%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 17%
Student > Master 13 12%
Student > Ph. D. Student 12 11%
Other 11 10%
Student > Bachelor 9 8%
Other 24 22%
Unknown 20 19%
Readers by discipline Count As %
Medicine and Dentistry 35 33%
Neuroscience 21 20%
Agricultural and Biological Sciences 20 19%
Nursing and Health Professions 2 2%
Biochemistry, Genetics and Molecular Biology 2 2%
Other 5 5%
Unknown 22 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 December 2023.
All research outputs
#17,042,920
of 25,046,311 outputs
Outputs from Orphanet Journal of Rare Diseases
#2,011
of 3,016 outputs
Outputs of similar age
#153,029
of 192,655 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#36
of 41 outputs
Altmetric has tracked 25,046,311 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 192,655 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 11th percentile – i.e., 11% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.